Research dossier
Clinical research on TQ
12 trials reviewed across 8 indications.
Strongest evidence
Blood sugar & HbA1c
Mechanism
Thymoquinone and other seed constituents appear to improve pancreatic beta-cell function, slow intestinal glucose absorption, and reduce hepatic glucose output in preclinical models. The human trials measure whole-seed effects; the exact contribution of thymoquinone itself is unproven.
Black seed's best-supported claim. Four meta-analyses (17–50 trials each) consistently show fasting glucose falling ~10–15 mg/dL and HbA1c ~0.5% at 1–3 g/day seed or 500–2,000 mg/day oil over 8–12 weeks. Notably, insulin and HOMA-IR did NOT improve in the pooled analyses.
Effects are concentrated in people with type 2 diabetes or prediabetes. If your glucose is normal, expect little. If you take glucose-lowering medication, the effect is additive — monitor for hypoglycemia.
Trials cited
Hallajzadeh — meta-analysis of 50 N. sativa trials (glucose, lipids, inflammation)
mixed · Meta-analysis
Hallajzadeh et al., 2020, Phytotherapy Researchn=50The largest pooled analysis: 50 trials. Fasting glucose fell 15.2 mg/dL, HbA1c 0.45%, total cholesterol 16.8 mg/dL, LDL 18.5 mg/dL, triglycerides 15.7 mg/dL vs control. But the anti-inflammatory story failed — CRP, TNF-alpha, and MDA changes were all non-significant.
High heterogeneity across trials; doses, preparations, and populations varied widely. Metabolic effects are consistent, but effect sizes differ by preparation.
Askari — meta-analysis of glycemic control trials
positive · Meta-analysis
Askari et al., 2019, Phytotherapy Researchn=1717 RCTs pooled: fasting glucose down 9.9 mg/dL, post-meal glucose down 14.8 mg/dL, HbA1c down 0.57%. Subgroup analysis found black seed oil more effective than seed powder for fasting glucose. Modest but consistent — roughly a third of what metformin does.
Benefits concentrate in people with elevated baseline glucose. No evidence this lowers glucose meaningfully in healthy normoglycemic adults.
Shirvani — updated glycemic meta-analysis (30 trials)
mixed · Meta-analysis
Shirvani et al., 2024, Prostaglandins & Other Lipid Mediatorsn=30The most recent update (through Dec 2023, 30 studies) confirms significant reductions in fasting glucose and HbA1c — but found NO significant effect on fasting insulin or HOMA-IR insulin resistance. The glucose benefit is real; the 'fixes insulin resistance' claim is not supported.
Very high statistical heterogeneity (I² >92%) — trial quality and preparations vary a lot, so pooled numbers are directional, not precise.
Saadati — meta-analysis in prediabetes and type 2 diabetes
mixed · Meta-analysis
Saadati et al., 2022, Frontiers in Nutritionn=11In 11 RCTs restricted to prediabetes/T2DM, black seed improved fasting glucose, HbA1c, total and LDL cholesterol, CRP, and MDA. But post-OGTT glucose, fasting insulin, HOMA-IR, triglycerides, HDL, and BMI did not change overall. HDL rose only in people starting below 40 mg/dL.
The population where black seed looks best — people with established glucose dysregulation. Don't extrapolate these numbers to healthy users.
Cholesterol & triglycerides
Mechanism
Proposed HMG-CoA reductase modulation, increased LDL-receptor activity, and antioxidant protection of lipoproteins — mechanisms from preclinical work; the lipid changes themselves are documented in human trials.
Repeatedly replicated: meta-analyses of 22–50 trials show total cholesterol down ~17 mg/dL, LDL ~15–18 mg/dL, and triglycerides ~16 mg/dL vs control, with a small HDL rise in the 2024 update. Moderate, consistent, and about the same league as plant sterols — well short of statin territory.
Clearest in people with elevated baseline lipids. In the diabetes-only pooled analysis, triglycerides and HDL did not improve overall — the lipid response is not uniform across populations.
Hallajzadeh — meta-analysis of 50 N. sativa trials (glucose, lipids, inflammation)
mixed · Meta-analysis
Hallajzadeh et al., 2020, Phytotherapy Researchn=50The largest pooled analysis: 50 trials. Fasting glucose fell 15.2 mg/dL, HbA1c 0.45%, total cholesterol 16.8 mg/dL, LDL 18.5 mg/dL, triglycerides 15.7 mg/dL vs control. But the anti-inflammatory story failed — CRP, TNF-alpha, and MDA changes were all non-significant.
High heterogeneity across trials; doses, preparations, and populations varied widely. Metabolic effects are consistent, but effect sizes differ by preparation.
Rounagh — updated lipid meta-analysis (34 trials)
positive · Meta-analysis
Rounagh et al., 2024, Clinical Nutrition ESPENn=227834 trials pooled: significant reductions in total cholesterol, LDL, and triglycerides, plus a significant HDL increase. Reinforces the older Sahebkar lipid meta-analysis — the cholesterol effect is one of black seed's most consistently replicated findings.
Reported as standardized mean differences with substantial heterogeneity; the clinical magnitude is moderate (roughly 15–20 mg/dL off LDL in absolute terms per earlier meta-analyses), not statin-scale.
Saadati — meta-analysis in prediabetes and type 2 diabetes
mixed · Meta-analysis
Saadati et al., 2022, Frontiers in Nutritionn=11In 11 RCTs restricted to prediabetes/T2DM, black seed improved fasting glucose, HbA1c, total and LDL cholesterol, CRP, and MDA. But post-OGTT glucose, fasting insulin, HOMA-IR, triglycerides, HDL, and BMI did not change overall. HDL rose only in people starting below 40 mg/dL.
The population where black seed looks best — people with established glucose dysregulation. Don't extrapolate these numbers to healthy users.
Blood pressure
Mechanism
Preclinical work suggests calcium-channel and diuretic-like effects plus improved endothelial function; unconfirmed in humans as a mechanism.
One meta-analysis of 11 RCTs (860 people): systolic down 3.3 mmHg, diastolic down 2.8 mmHg after ~8 weeks. Real but small — lifestyle-change territory, not medication territory. Seed powder outperformed oil for this outcome.
Short-term data only. If you take blood-pressure medication, the effect stacks — check your readings. Not a treatment for diagnosed hypertension.
Sahebkar — blood pressure meta-analysis
positive · Meta-analysis
Sahebkar et al., 2016, Journal of Hypertensionn=860Systolic pressure fell 3.26 mmHg and diastolic 2.80 mmHg vs control — a real but small effect, comparable to a modest dietary change, not an antihypertensive drug. Seed powder outperformed oil for blood pressure.
Short-term trials only; no long-term blood pressure outcome data. The effect size would not replace medication for anyone with actual hypertension.
Asthma & airway support
Mechanism
Thymoquinone shows anti-histaminic and airway anti-inflammatory activity in preclinical models; the Koshak trial's eosinophil reduction is the best human signal that something immunological is happening.
A well-run 4-week RCT (1 g/day oil) improved asthma control scores and normalized blood eosinophils as an add-on to standard inhalers, and a 4-trial meta-analysis supports the control-score and FEV1 signal. Evidence is small and short — promising add-on, nothing more.
Every trial used black seed ON TOP of standard asthma therapy. Never substitute it for a controller inhaler — the improvement measured was modest even as an add-on.
Koshak — black seed oil for asthma control (RCT)
positive · RCT
Koshak et al., 2017, Phytotherapy Researchn=80Double-blind placebo-controlled trial in 80 asthmatics: ACT score improved to 21.1 vs 19.6 on placebo (p = 0.044) and blood eosinophils dropped significantly. FEV1 (lung function) improved by 4% predicted but missed statistical significance.
Small, short (4 weeks), 25% dropout, and the ACT difference (1.5 points) is below the 3-point threshold usually considered clinically meaningful. An add-on to inhalers — never a replacement.
He & Xu — asthma control meta-analysis
mixed · Meta-analysis
He & Xu, 2020, American Journal of Emergency Medicinen=4Pooling 4 RCTs: significant improvements in asthma control scores and FEV1, but no significant effect on peak expiratory flow, IL-4, or interferon-gamma. Supportive but thin — only 4 trials qualified.
Small evidence base with wide confidence intervals (the FEV1 CI barely excludes zero). Needs larger multicenter trials before this counts as established.
Liver enzymes in fatty liver (NAFLD)
Mechanism
Attributed to antioxidant and anti-steatotic effects of thymoquinone in animal NAFLD models; human data measures enzyme and ultrasound changes, not biopsy-proven histology.
In 5 small RCTs of diagnosed NAFLD patients, black seed improved ALT, AST, hs-CRP, and ultrasound fatty-liver grade over 8–12 weeks. Limited but coherent. No evidence of any liver benefit in healthy people, and no long-term outcome data.
Applies to diagnosed NAFLD only. Elevated liver enzymes need a medical workup first — don't self-treat abnormal labs with a supplement.
Tang — NAFLD meta-analysis
mixed · Meta-analysis
Tang et al., 2021, Phytotherapy Researchn=358In NAFLD patients, black seed improved ALT, AST, fasting glucose, HDL, hs-CRP, and ultrasound fatty-liver grade vs placebo. But total cholesterol, LDL, triglycerides, insulin, and TNF-alpha did not change in this population.
Only 5 small trials. Promising for liver enzymes in diagnosed NAFLD; no evidence of liver benefit in healthy people.
Body weight
Mechanism
Possibly secondary to improved glycemic control and small appetite effects; no established fat-loss mechanism in humans.
Meta-analysis of 13 trials found ~1.8 kg weight and 0.85 kg/m² BMI reduction vs placebo — modest, with very high heterogeneity, and waist circumference didn't change. The diabetes-population meta-analysis found no BMI change overall. Not a weight-loss supplement.
If a product markets black seed oil primarily for fat loss, that claim outruns the evidence.
Mousavi — obesity indices meta-analysis
mixed · Meta-analysis
Mousavi et al., 2018, Complementary Therapies in Medicinen=875Pooled effect: body weight down 1.76 kg and BMI down 0.85 kg/m² vs placebo — modest at best. Waist circumference did not change significantly. Black seed is not a weight-loss supplement in any meaningful sense; treat any weight effect as a small side benefit.
Very high heterogeneity (I² = 87%) for the weight outcome; the true effect could be substantially smaller than the pooled number.
Saadati — meta-analysis in prediabetes and type 2 diabetes
mixed · Meta-analysis
Saadati et al., 2022, Frontiers in Nutritionn=11In 11 RCTs restricted to prediabetes/T2DM, black seed improved fasting glucose, HbA1c, total and LDL cholesterol, CRP, and MDA. But post-OGTT glucose, fasting insulin, HOMA-IR, triglycerides, HDL, and BMI did not change overall. HDL rose only in people starting below 40 mg/dL.
The population where black seed looks best — people with established glucose dysregulation. Don't extrapolate these numbers to healthy users.
Inflammation & antioxidant claims
Mechanism
Thymoquinone is a potent NF-kB inhibitor and antioxidant in cell and animal studies — this is the source of most 'anti-inflammatory' marketing. Mechanistic findings do not establish clinical benefit.
The honest read: in the largest pooled analysis (50 trials), CRP, TNF-alpha, and MDA did NOT improve significantly. CRP reductions appear only in specific disease populations (type 2 diabetes, NAFLD). General 'fights inflammation' claims rest on lab studies, not on consistent human results.
If you're healthy and buying black seed oil to 'lower inflammation,' the pooled human data doesn't support that expectation.
Hallajzadeh — meta-analysis of 50 N. sativa trials (glucose, lipids, inflammation)
mixed · Meta-analysis
Hallajzadeh et al., 2020, Phytotherapy Researchn=50The largest pooled analysis: 50 trials. Fasting glucose fell 15.2 mg/dL, HbA1c 0.45%, total cholesterol 16.8 mg/dL, LDL 18.5 mg/dL, triglycerides 15.7 mg/dL vs control. But the anti-inflammatory story failed — CRP, TNF-alpha, and MDA changes were all non-significant.
High heterogeneity across trials; doses, preparations, and populations varied widely. Metabolic effects are consistent, but effect sizes differ by preparation.
Saadati — meta-analysis in prediabetes and type 2 diabetes
mixed · Meta-analysis
Saadati et al., 2022, Frontiers in Nutritionn=11In 11 RCTs restricted to prediabetes/T2DM, black seed improved fasting glucose, HbA1c, total and LDL cholesterol, CRP, and MDA. But post-OGTT glucose, fasting insulin, HOMA-IR, triglycerides, HDL, and BMI did not change overall. HDL rose only in people starting below 40 mg/dL.
The population where black seed looks best — people with established glucose dysregulation. Don't extrapolate these numbers to healthy users.
Tang — NAFLD meta-analysis
mixed · Meta-analysis
Tang et al., 2021, Phytotherapy Researchn=358In NAFLD patients, black seed improved ALT, AST, fasting glucose, HDL, hs-CRP, and ultrasound fatty-liver grade vs placebo. But total cholesterol, LDL, triglycerides, insulin, and TNF-alpha did not change in this population.
Only 5 small trials. Promising for liver enzymes in diagnosed NAFLD; no evidence of liver benefit in healthy people.
Thyroid function (Hashimoto's)
Mechanism
Proposed immunomodulatory effect on the autoimmune process (anti-TPO antibodies fell); mechanism speculative, from one trial.
A single 8-week RCT in 40 Hashimoto's patients found lower TSH and anti-TPO antibodies on 2 g/day seed powder. Interesting, unreplicated, and far too thin to act on. Filed under preliminary until an independent group reproduces it.
One small trial, never replicated. If you take levothyroxine, black seed's possible thyroid activity is a reason for monitoring, not a reason to supplement.
Farhangi — powdered black seed in Hashimoto's thyroiditis (RCT)
positive · RCT
Farhangi et al., 2016, BMC Complementary and Alternative Medicinen=4040 Hashimoto's patients: 8 weeks of 2 g/day seed powder reduced TSH and anti-TPO antibodies and raised T3 vs placebo, alongside small weight/BMI reductions. Intriguing — but it is one small trial.
Single trial, n=40, never independently replicated. Do not adjust thyroid medication based on this; thyroid effects also mean levothyroxine users need monitoring.
3 forms of TQ compared
Cold-pressed black seed oil (unstandardized)
TQ content is a lottery: measured range 0.003–0.8% w/w (~260-fold spread) across commercial products
Best forGeneral use; the form used in the asthma RCT and many glucose/lipid trialsMost trials used 500–2,000 mg/day of oil. The problem is that without stated standardization you don't know whether you're getting a trial-comparable thymoquinone dose or 1% of it — the 2022 Nutrients analysis found some oils with almost no TQ. If the label doesn't state a TQ percentage, treat the product as unverified.
metabolism500–2000 mgrespiratory1000–1000 mge.g. ThymoQuin (3% TQ)
TQ-standardized black seed oil extract
Standardized — typically 2–5% thymoquinone, vs ~0.1–1% in typical cold-pressed oils
Best forWhen you want a verified thymoquinone doseA 3% TQ oil at 200–500 mg/day delivers roughly 6–15 mg thymoquinone — at the top of what typical unstandardized oils provide at much larger volumes. Note the honesty catch: the clinical meta-analyses were mostly done on plain oils and seed powder, not on these newer standardized extracts, so standardization buys you label reliability, not stronger trial evidence. A conservative safety analysis suggests staying under ~48.6 mg TQ/day.
metabolism6–30 mgWhole seed powder (crushed/ground seeds)
Lower TQ per gram than oil, but delivers the full seed matrix
Best forGlucose, blood pressure, and the Hashimoto's trialMany of the diabetes trials and the single Hashimoto's RCT used 1–3 g/day of crushed or powdered seed. Interestingly, the blood-pressure meta-analysis found powder outperformed oil, while the glycemic meta-analysis favored oil for fasting glucose — the two preparations are not interchangeable. Cheap and traditional, but TQ content is low and variable.
metabolism1000–3000 mgblood-pressure1000–3000 mg
Are you deficient? Symptoms, risk groups, lab tests
Thymoquinone is a plant compound from black seed (Nigella sativa), not a nutrient — there is no dietary requirement and no such thing as thymoquinone deficiency. It is supplemented for the pharmacological effects of the seed's compounds on glucose, lipids, and blood pressure.
Side effects and drug interactions
Side effects
Digestive upset
Common · More likely above ~2 g/day of oil or 3 g/day of seed
Nausea, bloating, stomach burning, or a strong aftertaste — the most commonly reported issues in trials, usually mild and dose-related. Taking oil capsules with food helps.
Low blood sugar (with medication)
Uncommon
Black seed measurably lowers glucose, so stacked on top of diabetes medication it can push glucose too low. Documented as an additive pharmacological effect, not an idiosyncratic reaction.
Allergic reactions
Rare
Contact dermatitis is reported with topical black seed oil; systemic allergic reactions from oral use are rare but described in case reports.
Unknown long-term and high-TQ safety
Uncommon
Trials ran 4–12 weeks at up to ~3 g/day seed or 2 g/day oil with good tolerability and no liver or kidney safety signals. Beyond 12 weeks, and above ~48.6 mg/day of concentrated thymoquinone, safety is simply undocumented in humans.
Drug interactions
Combined-effect risk
warfarinapixaban/rivaroxabanaspirinclopidogrelBlack seed extract inhibits platelet aggregation and prolongs bleeding time in preclinical studies, with a human case report of decreased platelets. Thymoquinone also inhibits CYP2C9 in vitro — the enzyme that clears warfarin and phenytoin.
Avoid combining with anticoagulants or antiplatelet drugs without your prescriber's sign-off, and stop black seed at least 2 weeks before scheduled surgery.
Additive effect
metformininsulinsulfonylureas (glimepiride, gliclazide)Additive glucose-lowering — the same effect documented in the meta-analyses stacks on top of medication.
Monitor glucose more closely for the first few weeks and tell your prescriber; doses of medication may need adjustment. This is the best-documented interaction because the herb's glucose-lowering effect is directly measured in the trials.
Additive effect
antihypertensives (ACE inhibitors, ARBs, calcium-channel blockers, diuretics)Additive blood-pressure lowering (~3/3 mmHg from the herb alone).
Usually manageable — check your blood pressure after starting and flag dizziness or lightheadedness to your clinician.
Other
levothyroxinenarrow-therapeutic-index drugs (phenytoin, cyclosporine — theoretical)One RCT found black seed lowered TSH and anti-TPO in Hashimoto's patients, so thyroid-medication users could theoretically drift over-replaced. CYP2C9/CYP3A4 inhibition is documented in vitro only.
On thyroid medication, recheck TSH a few weeks after starting. For narrow-window drugs, mention black seed to your prescriber — theoretical, not demonstrated, risk.
Other critical caveats
- No human trial has ever tested isolated thymoquinone. Every RCT and meta-analysis on this page used whole black seed oil or seed powder — thymoquinone is the standardization marker, not the proven agent. Any product implying 'clinical evidence for pure TQ' is overreaching.
- Label roulette: a 2022 lab analysis found measured thymoquinone ranging from 3 to 809 mg per 100 g of oil across commercial products (~260-fold). Prefer products stating a verified TQ percentage; treat unstandardized oils as unknown-dose products.
- Avoid in pregnancy — black seed may affect uterine contractions and there is no adequate human safety data. Also avoid while breastfeeding and in children, where dosing and safety are unstudied.
- On blood thinners or antiplatelet drugs, black seed adds bleeding risk (platelet inhibition plus in-vitro CYP2C9 inhibition affecting warfarin clearance). Stop at least 2 weeks before surgery.
- The glucose and blood-pressure effects are real enough to stack with medication — monitor readings if you take antidiabetic or antihypertensive drugs.
- Everything here is an adjunct-sized effect: HbA1c −0.5%, LDL −15–18 mg/dL, blood pressure −3/3 mmHg. Black seed does not replace metformin, statins, blood-pressure medication, or asthma inhalers.
Frequently asked
Does thymoquinone actually work?
The honest answer has two layers. Isolated thymoquinone has never been tested in a human trial — zero RCTs. Whole black seed (Nigella sativa) oil and seed powder, where thymoquinone is the main active marker, have moderate evidence: multiple meta-analyses show fasting glucose down ~10–15 mg/dL, HbA1c down ~0.5%, LDL cholesterol down ~15–18 mg/dL, and blood pressure down ~3/3 mmHg, mostly in people with type 2 diabetes or elevated baselines. Those are modest, adjunct-sized effects — real, but not medication replacements.What's the difference between thymoquinone and black seed oil?
Thymoquinone (TQ) is the main bioactive compound inside black seed oil — typically about 0.1–1% of a cold-pressed oil, or 2–5% in standardized extracts. When a label lists 'thymoquinone,' it means the standardized TQ content of a black seed oil extract, not a purified compound. All the clinical research was done on the whole oil or seed, so a higher TQ percentage buys you dose reliability, not proportionally more proven benefit.How much should I take?
Match the trials: 500–2,000 mg/day of black seed oil or 1–3 g/day of seed powder, taken with food, for 8–12 weeks in the studies. If using a TQ-standardized extract, 3% oil at 200–500 mg/day gives roughly 6–15 mg thymoquinone; a conservative published safety estimate suggests staying under ~48.6 mg TQ/day. There's no established benefit to exceeding trial doses.What should I look for on a label?
A stated thymoquinone percentage, ideally with third-party verification. Lab analyses found up to a ~260-fold difference in actual TQ content between commercial oils — some products contained almost none. Cold-pressed oils typically run 0.1–1% TQ; standardized extracts state 2–5%. A label that just says 'black seed oil 1000 mg' with no TQ figure tells you nothing about whether it resembles the trial material.Is black seed oil safe?
In trials up to about 12 weeks it was well tolerated — mainly mild digestive complaints — and pooled analyses found no liver or kidney safety signals at trial doses. The real cautions are interactions: it stacks with blood thinners (bleeding risk), diabetes medication (hypoglycemia), and blood-pressure medication, and it should be avoided entirely in pregnancy and before surgery. Long-term safety beyond 12 weeks and high-dose concentrated TQ are unstudied.Will black seed oil help me lose weight?
Barely. The pooled trials show about 1.8 kg more weight loss than placebo over 2–3 months, with no significant change in waist circumference, and the diabetes-focused meta-analysis found no BMI change at all. If weight loss is the goal, black seed oil is not the tool.
References
- 01Examine.com — Nigella sativa
- 02Drugs.com — Black Seed (Natural Products monograph)
- 03MSKCC About Herbs — Nigella sativa
- 04Hallajzadeh et al. 2020 — meta-analysis of 50 N. sativa trials (Phytotherapy Research)
- 05Sahebkar et al. 2016 — blood pressure meta-analysis (Journal of Hypertension)
- 06Khaikin et al. 2022 — thymoquinone content of commercial products (Nutrients)
Last reviewed2026-08-20